作者:Ofra Levy、Mordechai Erez、Dalia Varon、Ehud Keinan
DOI:10.1016/s0960-894x(01)00588-1
日期:2001.11
Novel dibenzoazepine and 11-oxo-dibenzodiazepine derivatives area shown to be effective ventricular defibrillating drug candidates. They exhibit significant in vivo defibrillatory activity with no observed changes in ECG either before or after the VF event. These compounds also exhibit antifibrillatory activity by elevating the fibrillation threshold potential, all suggesting that such drugs could be used to treat VF either by themselves or together with electrical defibrillators. (C) 2001 Elsevier Science Ltd. All rights reserved.